ENTITY

Micurx Pharmaceuticals (0276457D US)

1
Analysis
Health CareChina
Micurx Pharmaceuticals Inc. discovers and develops novel antibiotics to combat drug-resistant bacterial infections. The Company offers a pipeline of discovery and development programs for the treatment of Gram-positive bacteria, Gram-negative bacteria and fungal infections. Micurx Pharmaceuticals operates and markets to customers in the United States and China.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x